Fig. 1From: A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposureExperimental protocol. Pregnant female mice received a single oral dose of 800Â mg/kg sodium valproate on E11.5. Minocycline (100Â mg/kg/day) or maraviroc (80Â mg/kg/day) was dissolved in drinking water and administered to dams from P1 to P21. Behavioral tests were performed in the order of open field test, Y-maze test, social affiliation test and marble burying test from the age of 6Â weeksBack to article page